All Updates

All Updates

icon
Filter
Partnerships
The New York Center for Rare Diseases (NYCRD) partners with Google Health and multiple genetic testing companies for genetic testing pilot
Precision Medicine
Nov 8, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Precision Medicine

Precision Medicine

Nov 8, 2023

The New York Center for Rare Diseases (NYCRD) partners with Google Health and multiple genetic testing companies for genetic testing pilot

Partnerships

  • The New York Center for Rare Diseases has partnered with genetic testing and bioinformatics company GeneDx, biotechnology company Pacific Biosciences (PacBio), and Google Health on genetic diagnoses for families in the Bronx living with rare diseases.

  • A pilot project will perform genomic testing on 50 patient-parent trios to see if PacBio's long-read sequencing can identify genetic alterations. Further, in order to analyze these genomes with PacBio's HiFi DNA and RNA sequencing, GeneDx expects to perform short-read whole-genome sequencing. The genomic data would be returned to Albert Einstein College of Medicine for analysis.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.